Menlo Park-based MyOme, a clinical whole genome analysis company helping families understand their risk for diseases, has announced the expansion of its rare disease test to include tandem repeat ...
Alnylam Pharma joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine: San Diego Saturday, September 20, 2025, 12:00 Hrs [IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback